Lipidio Pharma is pleased to announce that Gordon Foulkes, our CEO is presenting in the Company Entrepreneurial Showcase of the 2024 Dermatology Summit ahead of the JPM conference in San Francisco on Jan. 7^th, 2024.

Gordon will be presenting positive clinical data for Lipidio’s first in class therapeutic for treating Sebaceous Hyperplasia. This conference uniquely fosters investment and partnerships to help advance the next generation of innovations in dermatology.

For more information on the conference, visit the Dermatology Summit 2024 website »